291 related articles for article (PubMed ID: 10487397)
1. Drug-induced nail disorders: incidence, management and prognosis.
Piraccini BM; Tosti A
Drug Saf; 1999 Sep; 21(3):187-201. PubMed ID: 10487397
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced nail abnormalities.
Piraccini BM; Iorizzo M; Antonucci A; Tosti A
Expert Opin Drug Saf; 2004 Jan; 3(1):57-65. PubMed ID: 14680462
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced nail diseases.
Piraccini BM; Iorizzo M; Starace M; Tosti A
Dermatol Clin; 2006 Jul; 24(3):387-91. PubMed ID: 16798438
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced nail abnormalities.
Piraccini BM; Iorizzo M; Tosti A
Am J Clin Dermatol; 2003; 4(1):31-7. PubMed ID: 12477371
[TBL] [Abstract][Full Text] [Related]
5. Drug reactions affecting the nail unit: diagnosis and management.
Piraccini BM; Iorizzo M
Dermatol Clin; 2007 Apr; 25(2):215-21, vii. PubMed ID: 17430758
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced nail disorders.
Prescrire Int; 2014 Jul; 23(151):180-2. PubMed ID: 25162091
[TBL] [Abstract][Full Text] [Related]
7. Nail changes caused by systemic drugs or ingestants.
Daniel CR; Scher RK
Dermatol Clin; 1985 Jul; 3(3):491-500. PubMed ID: 3830510
[TBL] [Abstract][Full Text] [Related]
8. Drug-related nail disease.
Piraccini BM; Alessandrini A
Clin Dermatol; 2013; 31(5):618-26. PubMed ID: 24079591
[TBL] [Abstract][Full Text] [Related]
9. Miscellaneous nail presentations.
Bodman MA
Clin Podiatr Med Surg; 1995 Apr; 12(2):327-46. PubMed ID: 7600507
[TBL] [Abstract][Full Text] [Related]
10. Nail abnormalities associated with systemic pathologies.
Zaiac MN; Walker A
Clin Dermatol; 2013; 31(5):627-49. PubMed ID: 24079592
[TBL] [Abstract][Full Text] [Related]
11. Yellow nail syndrome in rheumatoid arthritis: a drug-induced disease?
David-Vaudey E; Jamard B; Hermant C; Cantagrel A
Clin Rheumatol; 2004 Aug; 23(4):376-8. PubMed ID: 15293107
[No Abstract] [Full Text] [Related]
12. Association between morphological changes of nail and nail arsenic level in patients with arsenicosis.
Shafiquzzaman M; Jahan MK; Rahman MM; Islam MT; Miah MA; Kamal M; Islam MM; Choudhury AM; Chowdhury SA; Mohammad N
Mymensingh Med J; 2009 Jan; 18(1):27-30. PubMed ID: 19182745
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide-induced melanonychia in a patient with steroid dependent nephrotic syndrome: A rare presentation.
Mehta S; Makkar V; Soha PM; Sethi S; Kaur S
Saudi J Kidney Dis Transpl; 2019; 30(4):978-981. PubMed ID: 31464259
[TBL] [Abstract][Full Text] [Related]
14. Nail toxicity induced by cancer chemotherapy.
Gilbar P; Hain A; Peereboom VM
J Oncol Pharm Pract; 2009 Sep; 15(3):143-55. PubMed ID: 19171552
[TBL] [Abstract][Full Text] [Related]
15. Melanonychia induced by topical 5-fluorouracil.
Baran R; Laugier P
Br J Dermatol; 1985 May; 112(5):621-5. PubMed ID: 4005160
[TBL] [Abstract][Full Text] [Related]
16. Yellow nail syndrome associated with penicillamine therapy.
Ilchyshyn A; Vickers CF
Acta Derm Venereol; 1983; 63(6):554-5. PubMed ID: 6198852
[TBL] [Abstract][Full Text] [Related]
17. Nail toxicities induced by systemic anticancer treatments.
Robert C; Sibaud V; Mateus C; Verschoore M; Charles C; Lanoy E; Baran R
Lancet Oncol; 2015 Apr; 16(4):e181-9. PubMed ID: 25846098
[TBL] [Abstract][Full Text] [Related]
18. Pitfall in pigmentation: pseudopods in the nail plate.
Haas N; Henz BM
Dermatol Surg; 2002 Oct; 28(10):966-7. PubMed ID: 12410686
[TBL] [Abstract][Full Text] [Related]
19. [The podiatric pathology of nail. The chronic nail dystrophies].
Duhard-Brohan E
Ann Dermatol Venereol; 2005 Oct; 132(10 Pt 1):767-73. PubMed ID: 16419507
[No Abstract] [Full Text] [Related]
20. The nail in the elderly.
Baran R
Clin Dermatol; 2011; 29(1):54-60. PubMed ID: 21146733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
